Evidence map›Paper›PMID 24933682›Full record

ArticleJournal of biomedical optics2014

Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cells.

Mariana C Potcoava, Gregory L Futia, Jessica Aughenbaugh, Isabel R Schlaepfer, Emily A Gibson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of biomedical optics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Toward QuantitativeFrontiers in cell and developmental biology · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mariana C PotcoavaUniversity of Colorado Denver, Department of Bioengineering, Anschutz Medical Campus, Mail Stop 8607, 12700 East 19th Avenue, Aurora, Colorado 80045.
Gregory L FutiaUniversity of Colorado Denver, Department of Bioengineering, Anschutz Medical Campus, Mail Stop 8607, 12700 East 19th Avenue, Aurora, Colorado 80045.
Jessica AughenbaughUniversity of Colorado Denver, Department of Bioengineering, Anschutz Medical Campus, Mail Stop 8607, 12700 East 19th Avenue, Aurora, Colorado 80045.
Isabel R SchlaepferUniversity of Colorado Denver, Department of Pharmacology, Anschutz Medical Campus, Mail Stop 8303, 12801 East 17th Avenue, Aurora, Colorado 80045.
Emily A GibsonUniversity of Colorado Denver, Department of Bioengineering, Anschutz Medical Campus, Mail Stop 8607, 12700 East 19th Avenue, Aurora, Colorado 80045.
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Targeting Lipid Oxidation for Prostate Cancer Imaging and TherapyK01CA168934 · NCI · UNIVERSITY OF COLORADO DENVER · PI SCHLAEPFER, ISABEL RUBIO · 2012 to 2016
$615k
NCATS NIH HHS UL1 TR001082NCI NIH HHS 1K01CA168934NCI NIH HHS K01 CA168934NCI NIH HHS P30 CA046934
6 · The paper itself

Abstract

Increasing interest in the role of lipids in cancer cell proliferation and resistance to drug therapies has motivated the need to develop better tools for cellular lipid analysis. Quantification of lipids in cells is typically done by destructive chromatography protocols that do not provide spatial information on lipid distribution and prevent dynamic live cell studies. Methods that allow the analysis of lipid content in live cells are therefore of great importance. Using micro-Raman spectroscopy and coherent anti-Stokes Raman scattering (CARS) microscopy, we generated a lipid profile for breast (T47D, MDA-MB-231) and prostate (LNCaP, PC3) cancer cells upon exposure to medroxyprogesterone acetate (MPA) and synthetic androgen R1881. Combining Raman spectra with CARS imaging, we can study the process of hormone-mediated lipogenesis. Our results show that hormone-treated cancer cells T47D and LNCaP have an increased number and size of intracellular lipid droplets and higher degree of saturation than untreated cells. MDA-MB-231 and PC3 cancer cells showed no significant changes upon treatment. Principal component analysis with linear discriminant analysis of the Raman spectra was able to differentiate between cancer cells that were treated with MPA, R1881, and untreated.

Indexed as

Breast NeoplasmsCell Line, TumorFemaleHumansLipid DropletsLipidsMaleMedroxyprogesterone AcetateMetriboloneMicroscopyMolecular ImagingProstatic NeoplasmsSpectrum Analysis, RamanLipidsMedroxyprogesterone AcetateMetribolone

Identifiers

PMID24933682
PMCPMC4059341
OpenAlexW2167380779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.